Cirrhotic Cardiomyopathy After Transplantation: Neither the Transient Nor Innocent Bystander

Manhal Izzy, Jae Kuen Oh, Kymberly D. Watt

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Cirrhotic cardiomyopathy in end-stage liver disease is currently characterized by blunted contractile systolic response to stress with or without diastolic dysfunction in the absence of known heart disease. Since the establishment of the diagnostic criteria of cirrhotic cardiomyopathy in 2005, there have been multiple studies regarding its pathophysiology and pretransplant clinical course. The data regarding the post-transplant course of this entity are sparse. This review addresses the course and prognosis of the elements of cirrhotic cardiomyopathy after liver transplantation (LT). To this end, there is limited compelling evidence demonstrating the reversibility of this entity post-LT. Cirrhotic cardiomyopathy may, in fact, increase the risk of post-transplant complications. This review reveals a need to refine the diagnostic criteria of cirrhotic cardiomyopathy in view of the remarkable progress in the sphere of echocardiographic evaluation of systolic and diastolic dysfunction. The post-transplant course and outcomes related to cirrhotic cardiomyopathy may be better evaluated in the setting of updated diagnostic criteria.

Original languageEnglish (US)
Pages (from-to)2008-2015
Number of pages8
JournalHepatology
Volume68
Issue number5
DOIs
StatePublished - Nov 1 2018

Fingerprint

Cardiomyopathies
Transplantation
Transplants
Liver Transplantation
End Stage Liver Disease
Heart Diseases

ASJC Scopus subject areas

  • Hepatology

Cite this

Cirrhotic Cardiomyopathy After Transplantation : Neither the Transient Nor Innocent Bystander. / Izzy, Manhal; Oh, Jae Kuen; Watt, Kymberly D.

In: Hepatology, Vol. 68, No. 5, 01.11.2018, p. 2008-2015.

Research output: Contribution to journalReview article

Izzy, Manhal ; Oh, Jae Kuen ; Watt, Kymberly D. / Cirrhotic Cardiomyopathy After Transplantation : Neither the Transient Nor Innocent Bystander. In: Hepatology. 2018 ; Vol. 68, No. 5. pp. 2008-2015.
@article{ca3ac5557ef2408492b3b0417180b912,
title = "Cirrhotic Cardiomyopathy After Transplantation: Neither the Transient Nor Innocent Bystander",
abstract = "Cirrhotic cardiomyopathy in end-stage liver disease is currently characterized by blunted contractile systolic response to stress with or without diastolic dysfunction in the absence of known heart disease. Since the establishment of the diagnostic criteria of cirrhotic cardiomyopathy in 2005, there have been multiple studies regarding its pathophysiology and pretransplant clinical course. The data regarding the post-transplant course of this entity are sparse. This review addresses the course and prognosis of the elements of cirrhotic cardiomyopathy after liver transplantation (LT). To this end, there is limited compelling evidence demonstrating the reversibility of this entity post-LT. Cirrhotic cardiomyopathy may, in fact, increase the risk of post-transplant complications. This review reveals a need to refine the diagnostic criteria of cirrhotic cardiomyopathy in view of the remarkable progress in the sphere of echocardiographic evaluation of systolic and diastolic dysfunction. The post-transplant course and outcomes related to cirrhotic cardiomyopathy may be better evaluated in the setting of updated diagnostic criteria.",
author = "Manhal Izzy and Oh, {Jae Kuen} and Watt, {Kymberly D.}",
year = "2018",
month = "11",
day = "1",
doi = "10.1002/hep.30040",
language = "English (US)",
volume = "68",
pages = "2008--2015",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - Cirrhotic Cardiomyopathy After Transplantation

T2 - Neither the Transient Nor Innocent Bystander

AU - Izzy, Manhal

AU - Oh, Jae Kuen

AU - Watt, Kymberly D.

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Cirrhotic cardiomyopathy in end-stage liver disease is currently characterized by blunted contractile systolic response to stress with or without diastolic dysfunction in the absence of known heart disease. Since the establishment of the diagnostic criteria of cirrhotic cardiomyopathy in 2005, there have been multiple studies regarding its pathophysiology and pretransplant clinical course. The data regarding the post-transplant course of this entity are sparse. This review addresses the course and prognosis of the elements of cirrhotic cardiomyopathy after liver transplantation (LT). To this end, there is limited compelling evidence demonstrating the reversibility of this entity post-LT. Cirrhotic cardiomyopathy may, in fact, increase the risk of post-transplant complications. This review reveals a need to refine the diagnostic criteria of cirrhotic cardiomyopathy in view of the remarkable progress in the sphere of echocardiographic evaluation of systolic and diastolic dysfunction. The post-transplant course and outcomes related to cirrhotic cardiomyopathy may be better evaluated in the setting of updated diagnostic criteria.

AB - Cirrhotic cardiomyopathy in end-stage liver disease is currently characterized by blunted contractile systolic response to stress with or without diastolic dysfunction in the absence of known heart disease. Since the establishment of the diagnostic criteria of cirrhotic cardiomyopathy in 2005, there have been multiple studies regarding its pathophysiology and pretransplant clinical course. The data regarding the post-transplant course of this entity are sparse. This review addresses the course and prognosis of the elements of cirrhotic cardiomyopathy after liver transplantation (LT). To this end, there is limited compelling evidence demonstrating the reversibility of this entity post-LT. Cirrhotic cardiomyopathy may, in fact, increase the risk of post-transplant complications. This review reveals a need to refine the diagnostic criteria of cirrhotic cardiomyopathy in view of the remarkable progress in the sphere of echocardiographic evaluation of systolic and diastolic dysfunction. The post-transplant course and outcomes related to cirrhotic cardiomyopathy may be better evaluated in the setting of updated diagnostic criteria.

UR - http://www.scopus.com/inward/record.url?scp=85054786538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054786538&partnerID=8YFLogxK

U2 - 10.1002/hep.30040

DO - 10.1002/hep.30040

M3 - Review article

C2 - 29672903

AN - SCOPUS:85054786538

VL - 68

SP - 2008

EP - 2015

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 5

ER -